Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

325

307 Characterization of Volume Doubling Times of Lung Adenocarcinomas With Automated, Artificial Intelligence Volumetric Lesion Segmentation and Tracking/ A. Cypro, San Diego, CA 308 Liquid Biopsy in Lung Cancer. An Investigation of Methylated BCAT1 and IKZF-1 in Circulating Cell-free DNA in Lung Adenocarcinoma/ A.R. Rose, Bedford Park, Australia 309 Image Reconstruction of Pulmonary Nodules to Interrogate Deep Neural Networks Using Masked Autoencoders/ A.H. Masquelin, Burlington, VT 310 The Central Role Neck Ultrasound and Lymph Node Sampling Can Play in Modern Lung Cancer Diagnostics/ L. Power, Galway, Ireland 311 Bronchoscopic Pathological Confirmation of Incidental Chest Lesions on Dedicated Nuclear Medicine Prostate Imaging: True and False Positives in the Detection of Metastatic Prostate Cancer/ K. Kolbe, Ann Arbor, MI 312 Computerized Tomography-guided Transthoracic Biopsy in the Diagnosis of Hematologic Malignancies/ M.J. Cavaco, Torres Vedras, Portugal 313 Exosomes Contribution to the Establishment of the Pre-Metastatic Niche Through the Induction of the Epithelial-to-Mesenchymal Transition in Lymphangioleiomyomatosis (LAM): Implication of the Complement Cascade/ A. Jouida, Dublin, Ireland 314 Grape Seed Procyanidin Extract Modulates Inflammatory Medicators Within the Lungs of Heavy Active and Former Smokers/ J.T. Mao, San Diego, CA 315 Kynureninase Upregulation Is a Feature of NRF2-upregulated Lung Cancers and Is Associated With Tumor Immunosuppression and Poorer Prognosis/ E. Ostrin, Houston, TX 316 Cigarette Smoke Activates the Angiogenic Switch in the Lung Cancer Field by Downregulating MicroRNA-1/ A. Korde, New Haven, CT 317 Demonstrating Clinical Utility for a Nasal Genomic Classifier for Lung Nodules: Addressing the Clinical Trial Learning Curve With a Familiarization Phase/ F.K. Madhani-Lovely, Reno, NV

216 OSA Interferes With Esketamine Treatment for PTSD in Veterans/ B. Nokes, La Jolla, CA 217 SDB Is Associated With Worsened Pain and Poor Sleep in Patients Using Opioids/ J.E. Orr, La Jolla, CA 218 Effect of Lemborexant Treatment on Polysomnographic Sleep Measures in Adults With Mild to Severe Obstructive Sleep Apnea/ M. Moline, Nutley, NJ 219 Development and Validation of a Clinical Score to Estimate 10-year Mortality And Major Non-fatal Cardiovascular Events (MACE) in Obstructive Sleep Apnea Patients/ M.J. Divo, Boston, MA 220 Modeling the Effects of Simulated Obstructive Apnea on Elastic Properties of Lung in Persons With Asthma/ S. Chavoshian, Toronto, Canada

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D31

IMAGING, BIOMARKERS, AND MACHINE LEARNING IN LUNG CANCER

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 144 A-C (Street Level)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

Chairing: M.N. Kammer, PhD, Nashville, TN P. Nana-Sinkam, MD, Richmond, VA 301 Patient Tissue Derived Ex Vivo Lung Tumor Models for Investigation of Tumor-Stromal Interactions and Response to Immune Targeted Therapy/ K. Goliwas, Birmingham, AL 302 Identifying Patients With Pulmonary Nodules From CT Radiology Reports Using Natural Language Processing (NLP)/ T.L. Dotson, Winston-Salem, NC 303 A Modified Combined Biomarker Model for the Risk Stratification of Indeterminate Pulmonary Nodules/ R. Paez, Nashville, TN 304 EHR-driven Machine-learning Model to Distinguish Benign From Malignant Pulmonary Nodules/ T.A. Lasko, Nashville, TN 305 Usefulness of Protocadherin GA12 and Cysteine ? Dioxygenase Type 1 Methylation Biomarkers Analysis in the Diagnosis of Lung Cancer/ D. Kang, Daejeon, Korea, Republic of 306 Theoretical Net Benefit of a Radiomics-based Computer

Aided Diagnosis Tool for Risk Stratification of Pulmonary Nodules/ R.Y. Kim, Philadelphia, PA

ATS 2023 • Washington, DC